WHO advises against Regeneron and GSK Covid-19 treatments
The World Health Organization ”strongly” recommends that the two antibodies no longer be used, some months after the FDA limited the use of one medicine and scrapped the other. (Corrected)
by christian bundgaard, translated by daniel pedersen
(Corrected Sept. 20: An earlier version of this article mistakenly stated that one of the drugs was made by Pfizer/Regeneron when it was actually Roche/Regeneron. MedWatch apologizes for the mistake).
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
EMA backs standard approval of two Covid-19 vaccines
For subscribers
Researchers suggest Covid-19 boosters could become obsolete
For subscribers
